Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Lower vs higher ketamine doses to reduce the oculocardiac reflex in eye surgery

Official title: Evaluation of Two Intravenous Doses of Ketamine in Reducing the Oculocardiac Reflex in Adult Patients Undergoing Ophthalmic Surgery: A Randomized Controlled Double-Blinded Trial

Run by Cairo University · NCT07708740 · Data updated 2026-11-12

A single-dose comparison tests whether 0.5 mg/kg IV ketamine works as well as 0.75 mg/kg IV for lowering the oculocardiac reflex in adults having eye surgery.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedDecember 30, 2027
Study endsDecember 30, 2027
Registry record updatedJuly 16, 2026
Trial IDNCT07708740 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 years old scheduled for elective ophthalmic surgery requiring extraocular muscle traction under general anesthesia, with ASA I–II.

Probably not a fit

Patients with contraindications to ketamine, preexisting cardiac conduction issues, glaucoma or high intraocular pressure, or ASA > II may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares two intravenous doses of ketamine (0.5 mg/kg vs 0.75 mg/kg) given during elective ophthalmic surgery under general anesthesia to see which dose better reduces the oculocardiac reflex. The OCR can cause bradycardia or other heart changes during eye muscle traction or eye pressure. The trial focuses on adult patients aged 18–65 with ASA I–II, and excludes those with ketamine contraindications or certain eye or heart conditions. Outcomes include OCR incidence and potential side effects related to ketamine emergence and psychomimetic effects.

Why it matters

Potential benefit: If the lower dose is as effective, patients may experience fewer side effects while maintaining protection against OCR.

How similar studies have gone: Prior work has explored ketamine dosing for OCR, but evidence in adults remains limited and this study aims to clarify optimal dosing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age from 18 to 65 years old.
* Both sexes.
* American Society of Anesthesiologists (ASA) physical status I, II.
* Scheduled for elective ophthalmic surgery involving extraocular muscle traction under general anesthesia.

Exclusion Criteria:

* Ketamine contraindications (e.g., hypersensitivity, uncontrolled hypertension)
* History of cardiac arrhythmia or conduction disorder
* Glaucoma or raised intraocular pressure
* ASA status greater than II
* Patient refusal.

Where it's running

  • Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.